Net Income - Daewoong Pharma (KRX:069620) - Alpha Spread

Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 138 700 KRW -0.93% Market Closed
Market Cap: 1.6T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Daewoong Pharma
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daewoong Pharma
Net Income Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Net Income
â‚©84.1B
CAGR 3-Years
87%
CAGR 5-Years
N/A
CAGR 10-Years
4%
Yuhan Corp
KRX:000100
Net Income
â‚©145.9B
CAGR 3-Years
16%
CAGR 5-Years
28%
CAGR 10-Years
5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Net Income
-â‚©35.4B
CAGR 3-Years
48%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Net Income
â‚©207.2B
CAGR 3-Years
87%
CAGR 5-Years
35%
CAGR 10-Years
15%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Net Income
â‚©723.7m
CAGR 3-Years
N/A
CAGR 5-Years
-46%
CAGR 10-Years
-24%
C
Celltrion Pharm Inc
KOSDAQ:068760
Net Income
â‚©11.5B
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
8%

See Also

What is Daewoong Pharma's Net Income?
Net Income
84.1B KRW

Based on the financial report for Jun 30, 2024, Daewoong Pharma's Net Income amounts to 84.1B KRW.

What is Daewoong Pharma's Net Income growth rate?
Net Income CAGR 10Y
4%

Over the last year, the Net Income growth was 61%. The average annual Net Income growth rates for Daewoong Pharma have been 87% over the past three years , and 4% over the past ten years .

Back to Top